Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (181-190 of 302) with videos related to

Pageof 31
Sort By:
British Journal of Clinical Pharmacology|April 23, 2021
Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoringAndrea Calcagno, Amedeo de Nicolò, Costanza Pizzi, et al.
BMC Anesthesiology|June 17, 2014
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndromeFrancesco Giuseppe De Rosa, Vito Fanelli, Silvia Corcione, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2008
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphismAna Garcia-Diaz, Chun Bong Lok, Chun Blok, et al.
AIDS and Behavior|July 30, 2024
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational StudyMattia Trunfio, Elisa Vuaran, Daniela Vai, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2012
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriersLaurenzia Ferraris, Ottavia Viganò, Anna Peri, et al.
Biomedical Optics Express|July 25, 2017
Wavefront sensorless adaptive optics OCT with the DONE algorithm for <i>in vivo</i> human retinal imaging [Invited]Hans R G W Verstraete, Morgan Heisler, Myeong Jin Ju, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitisStefano Bonora, Gianluigi Zanusso, Riccardo Raiteri, et al.
AIDS (London, England)|September 27, 2014
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individualsGurmit J Singh, Akil Jackson, Antonio D'Avolio, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic VariantsJessica Cusato, Valeria Avataneo, Miriam Antonucci, et al.
Pageof 31

Showing results (181-190 of 302) with videos related to

Sort By:
Pageof 31
British Journal of Clinical Pharmacology|April 23, 2021
Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoringAndrea Calcagno, Amedeo de Nicolò, Costanza Pizzi, et al.
BMC Anesthesiology|June 17, 2014
Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndromeFrancesco Giuseppe De Rosa, Vito Fanelli, Silvia Corcione, et al.
AIDS (London, England)|October 9, 2002
Clinical use of lopinavir/ritonavir in a salvage therapy setting: pharmacokinetics and pharmacodynamicsMarta Boffito, Isabella Arnaudo, Riccardo Raiteri, et al.
The Journal of Antimicrobial Chemotherapy|September 13, 2008
Detection of low-frequency K103N mutants after unstructured discontinuation of efavirenz in the presence of the CYP2B6 516 TT polymorphismAna Garcia-Diaz, Chun Bong Lok, Chun Blok, et al.
AIDS and Behavior|July 30, 2024
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational StudyMattia Trunfio, Elisa Vuaran, Daniela Vai, et al.
The Journal of Antimicrobial Chemotherapy|June 5, 2012
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriersLaurenzia Ferraris, Ottavia Viganò, Anna Peri, et al.
Biomedical Optics Express|July 25, 2017
Wavefront sensorless adaptive optics OCT with the DONE algorithm for <i>in vivo</i> human retinal imaging [Invited]Hans R G W Verstraete, Morgan Heisler, Myeong Jin Ju, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitisStefano Bonora, Gianluigi Zanusso, Riccardo Raiteri, et al.
AIDS (London, England)|September 27, 2014
No pharmacokinetic interaction between raltegravir and amlodipine: importance for co-prescribing in ageing HIV-infected individualsGurmit J Singh, Akil Jackson, Antonio D'Avolio, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic VariantsJessica Cusato, Valeria Avataneo, Miriam Antonucci, et al.
Pageof 31